With a focus on complex chemistry and niche therapy areas, sz para has built a unique portfolio around Oncology, Contrast Media, Colored APIs, Peptides, Hormonals, Iron products, Injectable APIs etc.
We currently have 110+ US DMFs and 20+ CEPs along with regulatory filings across Canada, China, Korea, MENA and other global markets
At any point in time, our research team is working on 20+ development projects with an objective to deliver robust and quality products to the market in the shortest possible time
Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects. APIs find application in high quality drugs that treat diseases pertaining to oncology, cardiology, CNS and neurology, orthopaedic, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology. APIs can potentially create a more sustainable healthcare system by introducing more innovative products.
global portfolio in Active Pharmaceutical Ingredient (API) caters to over 1200 pharma companies in 100+ countries including the U.S, Europe and large emerging markets, with a track-record of excellence for over 20 years.
The information provided in the download document is drafted for pharmaceutical executives, research and development (R&D) executives, quality control and quality assurance executives, as well as API manufacturers, distributors, suppliers, sales managers, process engineers, technicians, research associates and production chemists, and any other individuals involved in the operations of the API and active pharmaceutical intermediates industry.